We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M Turnover 60.61%
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
+$8.29M
Cap. Flow
+$2.99M
Cap. Flow %
4.5%
Top 10 Hldgs %
32.21%
Holding
297
New
108
Increased
49
Reduced
51
Closed
72
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$3.53M
2
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$2.94M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.18M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.54M
5
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.37M

Top Sells

Rank Stock Value
1
GIS icon
General Mills
GIS
+$2.52M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.31M
3
AMGN icon
Amgen
AMGN
+$2.08M
4
ABT icon
Abbott
ABT
+$1.72M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.56M

Sector Composition

Rank Sector Weight
1 Healthcare 43.45%
2 Miscellaneous 41.8%
3 Consumer Discretionary 7.1%
4 Consumer Staples 6.25%
5 Communication Services 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
HLF icon
126
PUT
Herbalife
HLF
$1.44B
$47K 0.07%
+30,000
New +$1.03M
2017 Q3
0 quarters
JUNO
127
DELISTED
Juno Therapeutics, Inc.
JUNO
$45K 0.07%
+1,000
New +$34.1K
2017 Q3
0 quarters
SAGE icon
128
CALL
DELISTED
Sage Therapeutics
SAGE
$44K 0.07%
+3,300
New +$259K
2017 Q3
0 quarters
VZ icon
129
CALL
Verizon
VZ
$185B
$44K 0.07%
30,000
+12,500
+71% +$588K
2015 Q4
7 quarters
JWN icon
130
CALL
DELISTED
Nordstrom
JWN
$43K 0.06%
+58,000
New +$2.69M
2017 Q3
0 quarters
DVA icon
131
PUT
DaVita
DVA
$11.2B
$41K 0.06%
25,000
-8,500
-25% -$512K
2017 Q1
2 quarters
FOLD icon
132
PUT
DELISTED
Amicus Therapeutics
FOLD
$41K 0.06%
+35,100
New +$464K
2017 Q3
0 quarters
HSIC icon
133
PUT
Henry Schein
HSIC
$9.44B
$40K 0.06%
+30,345
New +$2.07M
2017 Q3
0 quarters
COL
134
CALL
DELISTED
Rockwell Collins
COL
$40K 0.06%
+11,000
New +$1.34M
2017 Q3
0 quarters
ONCE
135
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$37K 0.06%
+20,000
New +$1.52M
2017 Q3
0 quarters
ILMN icon
136
PUT
Illumina
ILMN
$40.5B
$36K 0.05%
7,299
– –
2017 Q2
1 quarter
RCKT icon
137
Rocket Pharmaceuticals
RCKT
$257M
$36K 0.05%
5,000
-32,500
-87% -$149K
2015 Q4
7 quarters
GGP
138
DELISTED
GGP Inc.
GGP
$36K 0.05%
+1,757
New +$38.4K
2017 Q3
0 quarters
TMUS icon
139
CALL
T-Mobile US
TMUS
$169B
$34K 0.05%
+20,100
New +$1.26M
2017 Q3
0 quarters
GWPH
140
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$34K 0.05%
9,100
– –
2015 Q4
7 quarters
TTPH
141
CALL
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$34K 0.05%
+3,750
New +$502K
2017 Q3
0 quarters
DBVT icon
142
PUT
DBV Technologies S.A. American Depositary Shares
DBVT
$596M
$33K 0.05%
+2,450
New +$1.05M
2017 Q3
0 quarters
GIS icon
143
PUT
General Mills
GIS
$17.9B
$33K 0.05%
5,000
-58,000
-92% -$3.18M
2016 Q1
6 quarters
UTHR icon
144
CALL
United Therapeutics
UTHR
$23.8B
$33K 0.05%
+10,700
New +$1.37M
2017 Q3
0 quarters
CL icon
145
CALL
Colgate-Palmolive
CL
$75.4B
$32K 0.05%
31,500
-33,300
-51% -$2.4M
2016 Q1
6 quarters
BIG icon
146
CALL
DELISTED
Big Lots, Inc.
BIG
$32K 0.05%
+8,200
New +$404K
2017 Q3
0 quarters
SIOX
147
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$32K 0.05%
22,350
+21,975
+5,860% +$3.71M
2017 Q1
2 quarters
KHC icon
148
PUT
The Kraft Heinz Company
KHC
$28.3B
$30K 0.05%
2,000
– –
2017 Q2
1 quarter
MOS icon
149
CALL
The Mosaic Company
MOS
$5.68B
$30K 0.05%
+15,000
New +$325K
2017 Q3
0 quarters
PRGO icon
150
CALL
Perrigo
PRGO
$2.24B
$29K 0.04%
+15,000
New +$1.17M
2017 Q3
0 quarters
4 5
6
7 8

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2017 Portfolio in Review

As of Q3 2017, FT Options held 297 positions worth $66.4M, up 14% from $58.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FT Options deployed $2.99M of net new capital in Q3 2017, opening 108 new positions and adding to 49 existing holdings. Its largest new stake was Incyte: 27,887 shares worth $3.26M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

On the sell side, the largest reduction was General Mills, an estimated $2.52M trimmed.

  • FT Options's largest Q3 2017 buy was Incyte: 27,887 shares worth $3.26M.
  • FT Options added most to Sio Gene Therapies Inc. Common Stock in Q3 2017, an estimated $1.37M increase.
  • FT Options's biggest Q3 2017 reduction was General Mills, cutting an estimated $2.52M.
  • FT Options fully exited Portola Pharmaceuticals, Inc. in Q3 2017, selling an estimated $2.31M.
  • FT Options's ten largest holdings make up 32% of its $66.4M portfolio in Q3 2017.
  • FT Options opened 108 new positions and closed 72 in Q3 2017.
  • FT Options's portfolio value rose 14% quarter-over-quarter to $66.4M.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.